reference/10074324

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10074324

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review
endingPage	42
issn	1524-4539 0009-7322
issueIdentifier	22
pageRange	e339-42
publicationName	Circulation
startingPage	e339
bibliographicCitation	Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA, Cooper LT, Link MS, Maron MS; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01;132(22):e273–80. doi: 10.1161/cir.0000000000000239. PMID: 26621644.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_377aa5f78e7f189e8514fce90d928f53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e0eb1e605a07e36f9b833cf6947d0e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07dd203d569b740321a887bc7245a9cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f7661bf071fc1ee6349229872944cdf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96500f6a529ea5ad4c6d7e238ee41637 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_240558cc9f328c1a53aad515d3a59518 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3aedee26daec0dd10e29d8a92695314b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba668eeac30bac5dc4ee114110d4c396 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6210a86c42d949f6a871adb654d6b665
date	2015-12-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1161/cir.0000000000000239 https://doi.org/10.1161/cir.0000000000000244 https://doi.org/10.1161/cir.0000000000000241 https://doi.org/10.1161/cir.0000000000000249 https://pubmed.ncbi.nlm.nih.gov/26621644 https://pubmed.ncbi.nlm.nih.gov/26621649 https://pubmed.ncbi.nlm.nih.gov/26621646 https://pubmed.ncbi.nlm.nih.gov/26621653
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2979 https://portal.issn.org/resource/ISSN/1524-4539 https://portal.issn.org/resource/ISSN/0009-7322
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000572 http://id.nlm.nih.gov/mesh/D018376Q000175 http://id.nlm.nih.gov/mesh/D002312Q000175 http://id.nlm.nih.gov/mesh/D002309Q000592 http://id.nlm.nih.gov/mesh/D009205Q000175 http://id.nlm.nih.gov/mesh/D056352 http://id.nlm.nih.gov/mesh/D019571Q000175
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018376Q000453 http://id.nlm.nih.gov/mesh/D009202Q000453 http://id.nlm.nih.gov/mesh/D026683 http://id.nlm.nih.gov/mesh/D019571Q000453 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009202Q000175 http://id.nlm.nih.gov/mesh/D017410Q000592 http://id.nlm.nih.gov/mesh/D014481Q000453 http://id.nlm.nih.gov/mesh/D002312Q000453 http://id.nlm.nih.gov/mesh/D009205Q000453 http://id.nlm.nih.gov/mesh/D002309Q000379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7931 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7179 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8563 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8565 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10384 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11156 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10254

Showing number of triples: 1 to 60 of 60.